Melanoma is the most aggressive skin cancer once metastasis begins; therefore , it is important to characterize the molecular players involved in melanoma dissemination. The chemokine receptor CXCR4 and the membrane-bound metalloproteinase MT1-MMP are expressed on melanoma cells and represent candidate molecules for the control of metastasis. Using human melanoma transfectants that either overexpress or silence CXCR4 or MT1-MMP , or that have a combination of overexpression and interference of these proteins , we show that CXCR4 and MT1-MMP coordinate their activities at different steps along melanoma cell metastasis into the lungs. Results from in vivo xenograft mouse models of melanoma lung colonization and mice survival and shortterm , homing nested polymerase chain reaction experiments from lung samples indicated that CXCR4 is required at early phases of melanoma cell arrival in the lungs. In contrast , MT1-MMP is not needed for these initial steps but promotes subsequent invasion and dissemination of the tumor with CXCR4. Investigation of potential cross talk between CXCR4 and MT1-MMP revealed that MT1-MMP accumulates intracellularly after melanoma cell stimulation with the CXCR4 ligand CXCL12, and that this process involves the activation of the Rac-Erk1/2 pathway. Subsequent to cell contact with specific basement membrane proteins, MT1-MMP redistributes to the cell membrane in a phosphatidylinositol 3-kinase-dependent manner. These results suggest that combination therapies that target CXCR4 and MT1-MMP should improve the limitations of the current therapies for metastatic melanoma.
Trafficking of cancer cells from primary tumor sites via intravasation into blood circulation and later extravasation to colonize distant organs requires tightly regulated directional cues and cell migration and extracellular matrix (ECM) degradation that are mediated by chemokines, growth factors, integrins, and metalloproteinases. 1 Solid tumor cells express chemokine receptors that provide guidance to these cells to organs where their ligands are expressed, constituting a homing model resembling the one used by immune cells to exert their immune surveillance functions.
CXCR4 is a chemokine receptor expressed by tumor cells in melanoma, breast, prostate, and colon cancer. [3] [4] [5] [6] Its ligand CXCL12 (also called SDF-1) is expressed in lymph nodes, lungs, bone marrow, and liver. 3 The importance of the CXCR4/CXCL12 axis in cancer is exemplified by the fact that blocking CXCR4 function leads to inhibition of metastasis in in vivo mouse models of breast carcinoma and pancreatic cancer. 3, 7, 8 Melanoma incidence has been steadily growing in western populations. Although melanoma only accounts for less than 5% of skin cancers, current therapies are primarily refractory for metastatic melanoma. Therefore, melanoma is responsible for 80% of deaths from skin cancers. 9 Expression of CXCR4 in human melanoma has been detected in the vertical growth phase and on regional lymph nodes and correlated with poor prognosis and increased mortality. 10, 11 We previously demonstrated that CXCL12 stimulates in vitro melanoma cell invasion involving Vav-Rho GTPase activation, as well as activation of the metalloproteinase MT1-MMP/MMP-2 ECM-degrading system. 12, 13 MT1-MMP is a key component of the pericellular proteolysis machinery involved in degradation of gelatin, laminin, and fibrillar collagens and is an activator of pro-MMP-2 in coordination with TIMP-2.
14,15 Accordingly, its cell membrane expression must be tightly controlled to avoid excessive ECM pericellular degradation. Furthermore, MT1-MMP proteolytic activity controls cell adhesion and growth.
14,15 MT1-MMP is expressed on melanoma, and breast and lung cancer, and its expression often correlates with tumor invasiveness across tissue barriers. 16 -19 MT1-MMP and MMP-2 are found in malignant melanoma often associated to the invading tumor front, 20, 21 suggesting that their proteolytic activity could be involved in melanoma cell dissemination.
Whereas the above data support an important role for CXCR4 and MT1-MMP in melanoma metastasis, the potential functional relationships and mechanistic coordination of these molecules in lung metastasis, as well as their roles at different steps of melanoma cell homing into lungs, have not been evaluated. In the present study we have generated stable transfectants of the highly metastatic human melanoma cell line BLM expressing combinations of overexpression and silencing of CXCR4 and MT1-MMP to investigate whether these proteins establish coordinated activities during in vivo melanoma metastasis. The results reveal that CXCR4 and MT1-MMP need each other's activities during melanoma metastasis into lungs and provide mechanistic characterization of molecular cross-talks between these proteins. The data suggest that combinatorial therapies against these proteins might provide beneficial advantages to inhibit melanoma metastasis.
Materials and Methods

Cells, Antibodies, and Reagents
BLM human melanoma cells were cultured as previously described. 4 Anti-CXCR4 antibodies were from R&D Systems (Minneapolis, MN), anti-MT1-MMP LEM-2/15 mAb was a gift from Dr. Alicia G. Arroyo (Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain), and control P3X63 and antibodies to ␤1 and ␣4 integrins (Lia 1/2.1 and HP1/2, respectively) were from Dr. Francisco Sá nchez-Madrid (Hospital de la Princesa, Madrid, Spain). Anti-Rac1 antibodies were from BD Biosciences (San Diego, CA), anti-RhoA from Santa Cruz Biotechnology (Santa Cruz, CA), anti-␤-actin from Sigma-Aldrich (St. Louis, MO), anti-GFP from Molecular Probes (Eugene, OR), and anti-Erk1/2, anti-phospho-Erk1/2, antiAkt, and anti-phospho-Akt (Ser473) antibodies were from Cell Signaling Technology (Danvers, MA). Type IV collagen and LY294002 were from Sigma-Aldrich Co., and U0126 from Calbiochem (Darmstadt, Germany). We used a laminin 1-rich extract from Sigma-Aldrich (catalog no. L2020) as source for laminin. Transforming growth factor-␤1 and epidermal growth factor were obtained from R&D Systems.
Vectors, siRNA, Transfections, and Retroviral Gene Transfer
The pEGFP-C1 vector or GFP-fused forms of wild-type or activated V12-Rac1 were gifts from Dr. Francisco Sanchez-Madrid and were transfected into BLM cells following the described method. 13 siRNA for Rac1 has been earlier reported 22 and was transfected into BLM cells according to the published procedure.
13 CXCR4 and MT1-MMP shRNA vectors were based on 19-mer sequences (5Ј-GCAGTCCATGTCATCTACA-3Ј, for CXCR4; 5Ј-TTGGCAGCCTCTCACTACT-3Ј, for MT1-MMP), which constitute targets for siRNA-mediated interference. 13 Synthetic oligonucleotides (64-mer) that include these 19-mer sequences were synthesized, annealed, and ligated into pSuper vector as described. 23 pSuper cassettes coding CXCR4 or MT1-MMP shRNAs were cloned into pRETRO-Hygro vector, 24 generating pRETRO-Super-CXCR4 and pRETRO-Super-MT1-MMP. cDNAs for CXCR4 and MT1-MMP (from Dr. José Miguel Rodríguez-Frade, Centro Nacional de Biotecnología, Madrid, Spain, and Dr. Alicia G. Arroyo, respectively) were cloned into pRetro-Blast retroviral vector 24 for overexpression of CXCR4 and MT1-MMP (pRetro-CXCR4 and pRetro-MT1-MMP, respectively). Retroviral particles were obtained by co-transfecting these vectors with plasmids coding for retroviral proteins gag.pol (pNGVL-MLV-gag-pol) 25 and the vesicular stomatitis virus envelope glycoprotein (pNGVL-VSV-G), 26 into 293FT packaging cells using lipofectamine (Invitrogen Corp., Carlsbad, CA). Conditioned media containing viral particles were used to infect BLM cells, which were selected with blasticidin (Invitrogen Corp.) or hygromicin (Calbiochem), obtaining sublines with interference (CXCR4  lo and MT1  lo ),  overexpression (CXCR4  hi and MT1   hi   ), or simultaneous overexpression and interference of CXCR4 and MT1-MMP  (CXCR4  hi MT1  lo and CXCR4  lo MT1  hi ) . As a control, we infected BLM cells with empty pRETRO-containing viral particles to generate the mock subline.
Flow Cytometry, Western Blotting, and Zymography
Melanoma cells were incubated with primary antibodies, followed by incubation with fluorescein isothiocyanateconjugated secondary antibodies (DAKO A/S, Copenhagen, Denmark) and analysis in an Epics XL cytofluorometer (Beckman Coulter, Fullerton, CA). P3X63 was used as control primary antibody. For Western blotting, cell lysates were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and proteins transferred to membranes that were incubated with primary antibodies, followed by incubation with horseradish peroxidase-conjugated secondary antibodies. Proteins were visualized using SuperSignal chemiluminescent substrate (Pierce, Rockford, IL). For zymography we used the described method. 13 Briefly, cells were lysed in Laemmli buffer, and samples resolved on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels embedded with 1 mg/ml of fibrinogen (Calbiochem-Novabiochem Co., Darmstadt, Germany). Gels were rinsed in 2.5% Triton X-100, followed by incubation in 50 mmol/L Tris-HCl, pH 7.5, 10 mmol/L CaCl 2 , and 200 mmol/L NaCl. Gels were stained with Coomassie Blue, and areas of gelatinolytic activity were visualized as transparent bands.
Proliferation and Cell Cycle Assays
Cells (1.2 ϫ 10 5 ) were cultured in Dulbecco's modified Eagle's medium/fetal bovine serum 1% with or without CXCL12 (R&D Systems) (200 ng/ml), and after detachment, cells were counted in a Neubauer chamber. For cell cycle assays, cells were pulsed with 5Ј-bromodeoxyuridine (BrdU) (Sigma-Aldrich Co) (15 mol/L for 1 hour) and cultured for different times. Thereafter, cells were detached, fixed with 70% ethanol, permeabilized with 0.5% Triton X-100 in 2 mol/L HCl, and washed with 0.1 mol/L sodium tetraborate. Finally, cells were incubated with fluorescein isothiocyanate-conjugated antiBrdU antibodies (BD Biosciences), followed by analysis in a cytofluorometer. Cell cycle time was estimated as the interval necessary to have a ratio of BrdU-labeled cells in S phase to BrdU-labeled cells in G 2 phase equal as in 0 hours time.
Invasion and Adhesion Assays
Invasions across Matrigel were done as previously established. 12 Briefly, cells (3.5 ϫ 10 4 ) were loaded on the upper compartments of invasion chambers coated with Matrigel (BD Biosciences, Bedford, MA). The lower compartments were filled with invasion medium with or without CXCL12. Invasive cells were fixed, stained, and counted under a microscope. For adhesion to Matrigel, cells (6 ϫ 10 5 ) were labeled for 20 minutes at 37°C with 2Ј,7Ј-bis(carboxyethyl)-5(6Ј)-carboxyfluorescein-acetoxymethyl ester (Molecular Probes), and after pre-incubation with antibodies, cells in triplicates (3 ϫ 10 4 ) were loaded on 96-well dishes (Costar, Cambridge, MA) coated with Matrigel (1 g/ml). Cells were allowed to adhere for 10 minutes at 37°C and, on washing to remove unbound cells, adhesion was quantified using a fluorescence analyzer (Polarstar Galaxy, Offenburg, Germany).
Animal Studies
BALB/c SCID mice (Harlan, Indianapolis, IN) bred and maintained under specific pathogen-free conditions were used for xenograft studies. The Consejo Superior de Investigaciones Cientificas Ethics Committee (Madrid, Spain) approved the protocols used for experiments with mice. Mice were injected subcutaneously in the lateral thoracic wall or intravenously into the tail vein with 2 ϫ 10 6 cells resuspended in 0.2 ml of phosphate-buffered saline (PBS). Mice were daily inspected for local tumor growth and general condition, and were sacrificed when clear signs of respiratory stress were noted, or when subcutaneous tumors reached volumes of 2.5 cm 3 . For nested reverse transcriptase-polymerase chain reaction (RT-PCR), portions of lungs from mice inoculated with GFP-expressing melanoma transfectants were lysed in Tri-Reagent (Sigma-Aldrich Co.), and RNA was extracted and reverse-transcribed. PCR was performed using TaqDNA polymerase (Invitrogen Corp.) and outer primers for GFP: 5Ј-GACTGGGTGCTCAGGTAGTG-3Ј and 5Ј-GTAAACGGCCACAAGTTCAG-3Ј. A 1-l PCR product was further amplified using inner primers for GFP: 5Ј-TCGT-GACCACCCTGACCTAC-3Ј and 5Ј-TCACCTTGATGCCGT-TCTTC-3Ј. The first PCR profile was 35 cycles of 45-second denaturation at 94°C, 45-second annealing at 52°C, and 1-minute polymerization at 72°C. The second PCR was performed in the same way, except that only 30 cycles were performed and annealing was executed at 56°C. For positron emission tomography (PET) analyses, mice were anesthetized with isoflurane, followed by administration of [ 18 F]-fluorodeoxyglucose (624 Ϯ 49 Ci) via the tail vein before analyses. Mice were scanned in a dedicated small animal PET scanner (rPET; Suinsa, Madrid, Spain), and tomographic images reconstructed using a three-dimensional FBP algorithm creating 55 55 ϫ 55 images. Voxel size was 0.81 ϫ 0.81 ϫ 0.81 mm 3 , and the spatial resolution was 1.65 mm full width at half maximum isotropic. The energy window was 400 to 700 keV, and decay and dead-time corrections were applied. For computed tomography (CT) studies, mice were scanned using a CT scanner (HQT-Y15D, Suinsa) for small animals. CT acquisition was performed as follows: one bed position, 200 A, 50 kV, 200 m pixel size, and 360 projections. PET and CT images were co-registered using a marker-based rigid registration algorithm to obtain an initial realignment followed by a refinement step based on a mutual information registration algorithm.
Statistical Analyses
Data were analyzed by one-way analysis of variance followed by Tukey-Kramer multiple comparisons. In both analyses, the minimum acceptable level of significance was P Ͻ 0.05.
Results
In Vivo Melanoma Metastasis Requires CXCR4 and MT1-MMP Coordinated Activities
To investigate if functional coordination between CXCR4 and MT1-MMP is needed during melanoma cell metastasis, we made BLM melanoma stable transfectants with combined overexpression and silencing of these proteins to be subsequently tested in in vivo models of metastasis. To generate these transfectants, we used pRetro-Super and pRetro retroviral vectors as templates for stably silencing or for overexpression of CXCR4 and MT1-MMP, respectively (see Materials and Methods). After antibiotic selection, total transfectant populations were used for all experiments without subsequent cloning. Flow cytometry and Western blotting analyses of single CXCR4 or MT1-MMP transfectants revealed that CXCR4 lo and MT1 lo cells displayed minimal levels of CXCR4 and MT1-MMP expression, whereas CXCR4 hi and MT1 hi transfectants showed threefold and twofold higher expression of these proteins than mock counterparts, respectively ( Figure 1 , A and B). Accordingly, CXCR4
hi MT1 lo and CXCR4 lo MT1
hi double transfectants displayed overexpression and silencing of CXCR4 or MT1-MMP.
To in vitro characterize the invasive properties of transfectants, we subjected them to invasion assays across Matrigel, a basement membrane matrix extract rich in laminin, type IV collagen, heparan sulfate proteoglycans, and growth factors, which constitutes a valuable in vitro basis for assessing the invasive potential of tumor cells.
27
CXCR4
hi and MT1 hi cells showed increased CXCL12-promoted invasion compared with mock counterparts, whereas CXCR4 lo and MT1 lo knockdown cells barely invaded ( Figure 1C ). Interestingly, CXCR4
hi MT1 lo and CXCR4 lo MT1 hi transfectants displayed invasion levels similar to single knockdown CXCR4 lo and MT1 lo cells, suggesting that CXCR4 and MT1-MMP are mutually required for invasion of melanoma cells. In addition, CXCR4 hi and MT1 hi transfectants displayed higher degree of migration in wound-healing assays on Matrigel layers in the presence of CXCL12 than CXCR4 lo and MT1 lo counterparts (see Supplemental Figure S1A at http://ajp.amjpathol.org), together indicating that in vitro invasive and migratory properties of melanoma transfectants reflect CXCR4 and MT1-MMP expression levels. CXCR4 hi transfectants displayed a modest growth advantage in medium containing CXCL12, compared with CXCR4 lo cells ( Figure 1D ). Cell cycle analyses with BrdUpulsed cells showed that high CXCR4 expression was associated with shorter doubling times (22 hours) than CXCR4 knockdown cells (26 hours), or mock transfectants (24 hours) (Supplemental Figure S1B at http://ajp. amjpathol.org). Instead, changes in MT1-MMP expression did not influence cell cycle kinetics.
To investigate if functional mutual requirement between CXCR4 and MT1-MMP observed in in vitro invasion also takes place during in vivo metastasis, we first subcutaneously injected the melanoma transfectants into SCID mice and followed the growth and dissemination of the tumors. MT1
hi and CXCR4 lo MT1 hi tumors grew significantly faster than MT1 lo or CXCR4 hi MT1 lo ones ( Figure  2A ). Instead, silencing or overexpression of CXCR4 did not affect the growth rate of melanoma cells, suggesting that MT1-MMP, but not CXCR4, influences the growth of subcutaneous melanoma tumors, in agreement with the Western blotting analyses of CXCR4 and MT1-MMP expression on BLM melanoma transfectants. Loading controls were assessed with anti-RhoA antibodies. Shown is a representative result of three independent experiments (top) and densitometer analyses in arbitrary units showing fold induction of expression related to mock transfectants (bottom). C: Transfectants were subjected to Matrigel invasion assays toward CXCL12 or medium alone. Invasion was significantly up-regulated, *P Ͻ 0.05, or significantly inhibited, ⌬ P Ͻ 0.05, with respect to mock transfectant invasion. D: Transfectants (1.2 ϫ 10 5 ) were incubated in Dulbecco's modified Eagle's medium/1% fetal bovine serum, without (medium) or with CXCL12, and cell number was determined after the indicated times.
reported MT1-MMP role in cell proliferation. 19 None of the mice injected with CXCR4 lo or MT1 lo transfectants had invasive tumors. These tumors remained under the skin without crossing into thoracic or abdominal cavities (not shown), and no lung metastases were detected in these mice ( Figure 2B ). In contrast, subcutaneously-injected CXCR4 hi and MT1 hi melanoma cells reached the lungs and formed metastatic nodes (one to two tumor nodes: 45% and 60% of mice, respectively). Importantly, metastasis was impaired in CXCR4 When melanoma transfectants were intravenously inoculated, we found that CXCR4 lo and MT1 lo mice displayed significantly longer survival than CXCR4
hi and MT1 hi ones, respectively ( Figure 3A ). Lung examinations revealed that 70 to 90% of CXCR4 hi and MT1 hi mice had from five tumor nodes to widespread tumor dissemination ( Figure 3B ). All CXCR4 lo and MT1 lo mice eventually developed lung metastasis, but only 10% had five or more tumor nodes, indicating that high CXCR4 expression on melanoma cells conferred strong lung invasiveness. Notably, CXCR4
hi MT1 lo and CXCR4 lo MT1 hi mice showed a substantially prolonged survival compared with CXCR4 hi and MT1
hi counterparts, and high tumor node number or massive lung metastases were only observed in 15 to 35% of mice inoculated with the double transfectants ( Figure 3B) . Control experiments confirmed the expression of human GAPDH mRNA in addition to CXCR4 and MT1-MMP in the lung tumor samples (see Supplemental Figure S3 at http://ajp.amjpathol.org). These results indicate that CXCR4 and MT1-MMP on melanoma establish crucial coordinated activities for efficient lung colonization.
The Role of CXCR4 and MT1-MMP in Early Events of Melanoma Cell Homing into Lungs
To investigate CXCR4 and MT1-MMP involvement at initial migratory events during melanoma cell homing into lungs, we first performed nested PCR using lung tissue from mice intravenously inoculated with melanoma transfectants that had been transiently transfected with pEGFP-C1 as a reporter. Before PCR analyses, we verified by flow cytometry that all transfectants expressed similar GFP levels (not shown). A GFP transcript in the lungs of CXCR4 hi mice was consistently detected in the first round of nested PCR (outer primers) at 2 hours after inoculation, which further increased on 24 hours of inoculation, whereas no GFP transcript was seen in CXCR4 lo or Mock mice at these times ( Figure 3C ). However, a GFP product using the inners primers was evident at 2 hours and 24 hours in lungs from CXCR4 lo and Mock mice, in addition of CXCR4 hi counterparts. In contrast with CXCR4, we did not observe significant differences in nested PCR products from MT1 hi and MT1 lo mice after 24 hours of inoculation. Moreover, GFP transcript levels in lungs from CXCR4 hi MT1 lo mice using the outer primers were similar to those of CXCR4 hi counterparts, and CXCR4 lo MT1 hi mice displayed only traces of GFP products in the first round of nested PCR. Together, these data indicate that high CXCR4 expression provides melanoma cells with greater homing efficiency during early steps of lung colonization than CXCR4 knockdown cells, and suggest that MT1-MMP does not play relevant roles at these initial phases. Furthermore, we found that the earlier accumulation of CXCR4 hi melanoma cells in lungs led to a subsequent faster development of metastases in this organ because a higher frequency of CXCR4 hi mice displayed tumors nodes (one to two) that were detectable by PET-CT imaging sooner than CXCR4 lo mice ( Figure 3D ). Firm attachment to endothelium is a required step for posterior tumor cell invasion to form additional metastatic sites. 1 Immunohistochemistry analyses using antibodies against HMW-MAA (also known as melanoma chondroitin sulfate proteoglycan) revealed large clusters of melanoma cells around blood vessels in lungs from CXCR4 hi mice (see Supplemental Figure S4A at http://ajp.amjpathol. org). In agreement with earlier results, 28 we found that high CXCR4 expression provided melanoma cells with advantage to up-regulate their ␣4␤1-dependent attachment to VCAM-1 through CXCL12-promoted inside-out signaling. Thus, in vitro adhesion assays under flow conditions to VCAM-1 co-immobilized with CXCL12 revealed that CXCR4 hi cells had a fourfold higher resistance to detachment than CXCR4 lo or mock transfectants at shear stresses up to 5 dyne/cm 2 (see Supplemental Figure S4B that pertussis toxin and anti-␣4 mAb abolished attachment to VCAM-1 (not shown).
Erk1/2 MAP Kinase Regulates MT1-MMP Expression, Whereas Phosphatidylinositol 3-Kinase Controls MT1-MMP Cell Surface Redistribution
We previously showed that CXCL12 stimulates MT1-MMP expression in melanoma cells at mRNA and protein levels. 12 However, enhancement in total cellular MT1-MMP protein levels was not translated into increased cell membrane protein expression on Mock and CXCR4 hi transfectants ( Figure 4A , top and bottom), indicating a predominant intracellular localization of this metalloproteinase on CXCL12 stimulation. As expected, no induction of MT1-MMP was detected in CXCR4 lo transfectants. To address whether intracellular MT1-MMP might redistribute to the melanoma cell membrane after interaction with basement membranes and endothelial ligands, we analyzed its surface expression on CXCL12-stimulated cells plated on Matrigel or other substrates. Notably, nonstimulated transfectants displayed a significant increase in cell membrane MT1-MMP expression on plating them on Matrigel for 45 minutes, compared with cells incubated in invasion medium alone, and the increase was of higher magnitude on CXCL12-stimulated CXCR4 hi and mock transfectants ( Figure 4A , bottom). Correlating with CXCR4 silencing, no further up-regulation of cell membrane MT1-MMP levels was observed in CXCR4 lo transfectants pre-incubated with the chemokine. Kinetic studies indicated that Matrigel-triggered increase in surface MT1-MMP expression had a maximum at ϳ45 minutes, and then gradually decreased with longer incubations ( Figure 4B ). Because laminin and type IV collagen are main components of Matrigel, we tested their possible role in MT1-MMP redistribution to the melanoma cell membrane. We found that incubation on laminin led to an increase in cell surface MT1-MMP to levels similar to those achieved with Matrigel, whereas plating on type IV collagen did not induce such an effect ( Figure 4C ). In addition, incubation with transforming growth factor-␤1 or epidermal growth factor, which are also Matrigel constit- uents, or with VCAM-1, fibronectin, or gelatin, did not influence melanoma cell MT1-MMP membrane levels ( Figure 4C ; and see Supplemental Table S1 at http:// ajp.amjpathol.org). Control experiments indicated that 45-minute incubation with Matrigel, VCAM-1, fibronectin, or gelatin did not alter cell surface expression of CXCR4. Stimulation by CXCL12 of total MT1-MMP expression involved Erk1/2 MAP kinase activity because treatment with the MEK inhibitor UO126 led to inhibition of increase in the metalloproteinase expression, whereas the phosphatidylinositol 3-kinase (PI3-K) inhibitor LY294002 (LY) did not affect the enhanced expression ( Figure 5A ), as also earlier reported. 13 Because activation of Vav1-Rac1 signaling by CXCL12 controls up-regulation of MT1-MMP expression in melanoma, 13 we next tested whether Erk1/2 was a required Rac1 downstream target to increase this expression. When BLM melanoma cells were transfected with Rac1 siRNA, CXCL12-promoted enhancement in MT1-MMP expression was abrogated, which was associated with blockade in the stimulation of Erk1/2 phosphorylation ( Figure 5B ). Moreover, expression of a constitutively active Rac1 form (Rac CA) triggered both an increase in MT1-MMP expression and in Erk1/2 phosphorylation, compared with Rac wild-type transfectants that were inhibited by UO126 ( Figure 5C ). Notably, CXCL12-stimulated Rac CA transfectant invasion was inhibited by UO126 and blocked by anti-MT1-MMP mAb ( Figure 5D, left) . In addition, zymography assays showed that supernatants from Rac CA transfectant invasions contained higher amounts of active MMP-2 than in Rac wild-type counterparts, whereas the presence of UO126 in the invasions resulted in inhibition of pro-MMP-2 activation ( Figure 5D, right) . No MMP-9 was detected in the invasion supernatants under our assay 
MT1-MMP expression
Control
Mean Fluorescence Intensity BLM melanoma cells were transfected with control or Rac1 siRNA (B), or with GFP-fused wildtype (wt) or constitutively activated (CA) forms of Rac (C). Transfectants were subsequently incubated for 24 hours with CXCL12 and subjected to Western blotting for expression of MT1-MMP, phospho-Erk1/2, total Erk1/2, and Rac1. D: Transfectants expressing Rac wt or Rac CA were subjected to Matrigel invasion assays toward CXCL12, in the absence or presence of UO126 and control or anti-MT1-MMP mAb (left). Supernatants from these invasions were tested by gelatinolytic zymography for MMP-2 activity (right).
conditions (not shown). These results indicate that activation of Rac1-Erk1/2 pathway contributes to up-regulation of MT1-MMP expression and function, as revealed by MMP-2 activation and enhanced invasion. Interestingly, when nonstimulated or CXCL12-activated transfectants were treated with LY for 2.5 hours previous to the 45-minute period of incubation on Matrigel, induction of MT1-MMP cell membrane expression was largely reduced ( Figure 6A ). In contrast, no such inhibition was seen in cells treated with UO126, and because this inhibitor blocks up-regulation by CXCL12 of total MT1-MMP expression, surface levels of this metalloproteinase on chemokine-incubated cells exposed to Matrigel were similar to unstimulated counterparts. When we examined invasiveness, we found that LY and U0126 partially inhibited BLM cell invasion to CXCL12, whereas the p38 and JNK MAP kinase inhibitors SB203580 and JNK inhibitor II, did not affect invasion or MT1-MMP redistribution to the cell surface ( Figure 6, A and B) . Together, these results suggest that CXCL12 stimulates intracellular MT1-MMP accumulation through an Erk1/2 MAP kinase-dependent pathway, and that subsequently this metalloproteinase redistributes to the cell membrane after exposure to laminin-containing basement membranes in a PI3-K-dependent manner, a process that contributes to cell invasion.
Because laminin-1 is a ligand for ␤1 integrins and ␤1 integrin-mediated cell adhesion induces PI3-K activation, 29 we tested whether melanoma cell incubation on Matrigel triggered ␤1-mediated PI3-K activation, which might represent a mechanism accounting for MT1-MMP cell membrane expression. Anti-␤1 integrin antibodies blocked melanoma cell attachment to Matrigel, and inhibited Matrigel-dependent activation of Akt, a downstream PI3-K effector ( Figure 6, C and D) , suggesting that this mechanism could indeed mediate the redistribution of MT1-MMP to the cell membrane.
Discussion
The distinctive homing of tumor cells to organs and tissues during metastasis is contributed by specific attracting molecules, which recruit and promote migration of circulating tumor cells, and by tumor proteolytic enzymes that remodel pericellular ECM allowing cell invasion across tissue barriers to establish new metastatic sites. 1 Chemokines and metalloproteinases have been proposed to mediate these processes, leading to tumor cell dissemination into target organs. 2, 30 Studies addressing the individual roles of the chemokine receptor CXCR4 and the metalloproteinase MT1-MMP during in vivo metastasis of melanoma have shown that their overexpression on the murine B16 melanoma model leads to lung metastasis. 28, 31 However, characterization of CXCR4 and MT1-MMP involvement at different steps of melanoma cell homing into lungs, whether they are mutually required during metastasis, as well as whether they establish mechanistic relationships, has not yet been investigated. By generating in the same human melanoma cell line transfectants either silenced for CXCR4 or MT1-MMP expression, overexpressing these proteins, or having a combination of their silencing and overexpression, we demonstrate here using xenograft models that CXCR4 strongly contributes to early migratory steps in melanoma cell homing to lungs. Instead, MT1-MMP is dispensable for the initial phases, but together with CXCR4, it promotes subsequent invasiveness for efficient lung dissemination, indicating that these proteins are mutually required during different steps of melanoma cell metastasis.
In vitro transfectant characterization already revealed that invasive cell responses involving CXCR4 and MT1-MMP individually were not sufficient to promote invasion, but rather their coordinated activities were necessary. Subsequent in vivo approaches demonstrated that CXCR4 expression provides melanoma cells with metastatic advantage over CXCR4 knockdown cells during early steps of homing into lungs. This conclusion is based on data from nested PCR experiments that revealed that CXCR4 hi melanoma cells accumulated faster in the lungs in the first hours after intravenous inoculation than CXCR4 lo counterparts. In addition, adhesion assays showed that CXCR4 hi cells developed stronger attachment under shear stress on endothelial VCAM-1 co-immobilized with CXCL12 compared with CXCR4 lo counterparts. This in vitro result could mimic the melanoma adhesive steps in the lung endothelium, where CXCL12 might be exposed on VCAM-1-rich areas of endothelium, being capable of up-regulating ␣4␤1-mediated melanoma cell attachment leading to firm arrest. PET-CT analyses together with visual examination of melanoma lung metastases indicated that rapid and more efficient accumulation of CXCR4 hi cells in the lungs led to a posterior faster organ colonization, causing a notable survival shortening, as compared with CXCR4 lo mice. In contrast to CXCR4, we found that MT1-MMP was not needed in early phases of melanoma cell homing into lungs. However, the activity of this metalloproteinase together with CXCR4 was required for subsequent dissemination of the tumor because CXCR4 hi MT1 lo melanoma cells displayed a significant reduction in their aggressiveness in lungs, which was associated with prolonged mice survival. Additional evidence of mutual requirement between CXCR4 and MT1-MMP for efficient lung metastasis was provided by the observation that subcutaneouslyinoculated CXCR4 hi
MT1
lo and CXCR4 lo MT1 hi melanoma cells displayed a notable decrease in lung colonization compared with CXCR4 hi and MT1 hi single counterparts. The expression of MT1-MMP on the invading tumor front in melanoma, 21 its reported localization on melanoma invadopodia 20 together with our present in vivo data support an important role for MT1-MMP in melanoma lung colonization. Although our results strongly indicate that CXCR4 and MT1-MMP activities are functionally coordinated during different steps of melanoma cell trafficking into lungs, we cannot exclude that CXCR4 hi melanoma cells might take advantage of CXCL12-dependent growth properties 32, 33 to proliferate in the lungs with higher rates than CXCR4 lo counterparts, based on the shorter doubling times of CXCR4 hi cells in the presence of the chemokine.
Mutual requirement between CXCR4 and MT1-MMP could take place independently from each other's activity, but there might also be molecular cross-talks between them. Indeed, we previously reported that CXCL12 upregulates MT1-MMP expression in melanoma cells, involving Vav-Rho GTPase activation. 12, 13 Here we have further characterized this signaling, and thus we show that Erk1/2 MAP kinase represents a Vav-Rac1-activated downstream target that is required for stimulation of the expression and function of MT1-MMP in melanoma cells. It is well established that the Rac-PAK pathway contributes to the activation of MEK-Erk1/2 signaling, 34, 35 and therefore our data suggest that CXCL12-activated VavRac1-PAK-Erk1/2 pathway can promote enhancement of MT1-MMP expression in melanoma cells.
Cell membrane expression levels of MT1-MMP are generally low, with most of this metalloproteinase residing intracellularly, likely reflecting a tight cell regulation to avoid excessive pericellular proteolysis. In agreement with this expression pattern, MT1-MMP on BLM melanoma cells predominantly accumulates intracellularly, even if its expression is elevated by CXCL12. Interestingly, we have found that when cells come in contact with components of Matrigel basement membranes, especially with laminin, a phosphatidylinositol 3-kinase-dependent transient increase in MT1-MMP cell surface expression is detected, this increase being higher in CXCL12-incubated CXCR4 hi cells. These data indicate that melanoma cells control their MT1-MMP cell surface expression after contact with specific ECM proteins. Integrins transmit outside-in signals for PI3-K activation after interaction with their ECM ligands, 33 and thus are potential candidates to contribute to up-regulation of cell surface MT1-MMP expression. We show here that ␤1 integrins mediate melanoma cell attachment to Matrigel ECM proteins, which causes Akt activation, suggesting that ␤1 integrin-dependent PI3-K activation represents a mechanism likely regulating MT1-MMP cell membrane expression.
Involvement of PI3-kinase activity in protein trafficking, both in regulated exocytosis and endocytosis, has been demonstrated. 36 -39 In particular, class I and III (hVPS34) PI3-kinases regulate redistribution of surface proteins together with key members of the exocytic and endocytic pathways. Expression of MT1-MMP on the cell surface has been reported to be regulated, among other processes, by internalization, 40 -42 recycling, 43 autocatalysis, 44 and exocytosis. 45, 46 At present, it is not known whether PI3-K-mediated stimulation of exocytosis or inhibition of internalization account for the increase in MT1-MMP melanoma cell surface expression. Further studies are needed to better characterize the role of this kinase in MT1-MMP trafficking to the cell membrane, where it exerts its ECM pericellular remodeling.
Together, these data highlight the cross talk between CXCR4 and MT1-MMP for efficient melanoma cell invasion. Thus, expression of MT1-MMP is stimulated by CXCL12 leading to its intracellular accumulation and subsequent redistribution to the cell surface after cell contact with basement membrane proteins, a mechanism contributing to a greater invasiveness. Accordingly, changes in cell surface expression of CXCR4 on melanoma should strongly affect its coordinated activity with MT1-MMP during lung metastasis. Expression of CXCR4 in melanoma and in non-small cell lung cancer can be stimulated by transforming growth factor-␤1 and epidermal growth factor, respectively, 12,47 whereas its expression in breast cancer cells can be increased by HER2 signaling leading to lung metastasis. 48 Additional characterization of the mechanisms controlling CXCR4 expression will contribute to improve our knowledge of its metastasis-promoting properties.
Collectively, the results from the present work dissect independent and coordinated roles for CXCR4 and MT1-MMP during the metastasis of melanoma cells into lungs, establishing molecular cross-talks between these molecules, and suggest that combination therapies targeting CXCR4 and MT1-MMP should benefit and contribute to ameliorate the limitations of the current therapies in metastatic melanoma.
